Synthesis and Evaluation of 68Ga-Labeled (2S,4S)-4-Fluoropyrrolidine-2-Carbonitrile and (4R)-Thiazolidine-4-Carbonitrile Derivatives as Novel Fibroblast Activation Protein-Targeted PET Tracers for Cancer Imaging
Molecules · 14.04.2023 · 28 (8) · 3481
DOI: 10.3390/molecules28083481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 14.04.2023. Verfasst von Shreya Bendre und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research, Pancreas Centre BC.
Abstract (Originalsprache)
Fibroblast activation protein α (FAP-α) is a cell-surface protein overexpressed on cancer-associated fibroblasts that constitute a substantial component of tumor stroma and drive tumorigenesis. FAP is minimally expressed by most healthy tissues, including normal fibroblasts. This makes it a promising pan-cancer diagnostic and therapeutic target. In the present study, we synthesized two novel tracers, [68Ga]Ga-SB03045 and [68Ga]Ga-SB03058, bearing a (2S,4S)-4-fluoropyrrolidine-2-carbonitrile or a (4R)-thiazolidine-4-carbonitrile pharmacophore, respectively. [68Ga]Ga-SB03045 and [68Ga]Ga-SB03058 were evaluated for their FAP-targeting capabilities using substrate-based in vitro binding assays, and in PET/CT imaging and ex vivo biodistribution studies in an HEK293T:hFAP tumor xenograft mouse model. The IC50 values of natGa-SB03045 (1.59 ± 0.45 nM) and natGa-SB03058 (0.68 ± 0.09 nM) were found to be lower than those of the clinically validated natGa-FAPI-04 (4.11 ± 1.42 nM). Contrary to the results obtained in the FAP-binding assay, [68Ga]Ga-SB03058 demonstrated a ~1.5 fold lower tumor uptake than that of [68Ga]Ga-FAPI-04 (7.93 ± 1.33 vs. 11.90 ± 2.17 %ID/g), whereas [68Ga]Ga-SB03045 (11.8 ± 2.35 %ID/g) exhibited a tumor uptake comparable to that of [68Ga]Ga-FAPI-04. Thus, our data suggest that the (2S,4S)-4-fluoropyrrolidine-2-carbonitrile scaffold holds potential as a promising pharmacophore for the design of FAP-targeted radioligands for cancer diagnosis and therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
- Department of Functional Imaging, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
- Department of Radiology, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
ORCID-Profile: Antonio A W L Wong, François Bénard, Kuo-Shyan Lin
Förderung
- CIHR
- Canadian Institutes of Health Research
- Pancreas Centre BC
Zitieren
APA
Bendre, S., Zhang, Z., Colpo, N., Zeisler, J., Wong, A. A. W. L., Bénard, F., & Lin, K. S. (2023). Synthesis and Evaluation of 68Ga-Labeled (2S,4S)-4-Fluoropyrrolidine-2-Carbonitrile and (4R)-Thiazolidine-4-Carbonitrile Derivatives as Novel Fibroblast Activation Protein-Targeted PET Tracers for Cancer Imaging. Molecules, 28(8), 3481. https://doi.org/10.3390/molecules28083481
Vancouver
Bendre S, Zhang Z, Colpo N, Zeisler J, Wong AAWL, Bénard F, et al. Synthesis and Evaluation of 68Ga-Labeled (2S,4S)-4-Fluoropyrrolidine-2-Carbonitrile and (4R)-Thiazolidine-4-Carbonitrile Derivatives as Novel Fibroblast Activation Protein-Targeted PET Tracers for Cancer Imaging. Molecules. 2023;28(8):3481. doi:10.3390/molecules28083481
BibTeX
@article{Bendre2023,
author = {Bendre, Shreya and Zhang, Zhengxing and Colpo, Nadine and Zeisler, Jutta and Wong, Antonio A W L and Bénard, François and Lin, Kuo-Shyan},
title = {Synthesis and Evaluation of 68Ga-Labeled (2S,4S)-4-Fluoropyrrolidine-2-Carbonitrile and (4R)-Thiazolidine-4-Carbonitrile Derivatives as Novel Fibroblast Activation Protein-Targeted PET Tracers for Cancer Imaging},
journal = {Molecules},
year = {2023},
volume = {28},
number = {8},
pages = {3481},
doi = {10.3390/molecules28083481}
}
EUVIMED